Latest Updates

The company reported a 28.5 per cent growth in revenues at Rs 20,390 mn and a growth of 11.6 per cent in net profits for FY19;…

The company reported a 21 per cent hike in YoY total revenue at Rs. 9,111 Crore

The revenue for the quarter under discussion was up by 14 per cent at Rs 4,016.60 crore against Rs 3,534.90 crore in the same…

The drug regulator stated that the practice of changing the key therapeutic ingredients in a drug formulation without changing the…

The company has received US FDA final approval for its ANDA for Docetaxel Injection USP in the strengths of 20 mg/mL, 80 mg/4 mL…

Ogivri is the first biosimilar for Herceptin approved by the US Food and Drug Administration (FDA) for all indications including…

The drug developed by the firm, Abrocitinib, was found to have significantly improved clearing of the skin in patients as compared…

Centre for Cancer Drug Discovery, a new centre being set up will “seek to meet the challenge of cancer evolution head on” by…

The USFDA carried out the inspection at the plant from May 6 to May 15

Daptomycin for Injection is a a therapeutic equivalent generic version of Cubicin for Injection